Publications To Date


    Filter Publications

    PAGE 73 OF 80 | DISPLAYING 1081 - 1095 OF 1192 RESULTS

    Prat A. et al., Genomic analyses across six cancer types identify basal-like breast cancer as a unique molecular entity., [Epub ahead of print]., Scientific Reports, Dec 18, 2013

    Peterson V.M. et al., Ascites analysis by a microfluidic chip allows tumor-cell profiling., [Epub ahead of print]., PNAS, Dec 17, 2013

    Goard C.A. et al., Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells., [Epub ahead of print]., Breast Cancer Res Treat, Dec 17, 2013

    Gnant M. et al., Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone., [Epub ahead of print]., Annals Oncol., Dec 16, 2013

    Puig I. et al., A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells., [Epub ahead of print]., Clin Cancer Res., Dec 15, 2013

    Tan S. et al., Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma., [Epub ahead of print]., Clin. Cancer Res., Dec 09, 2013

    Spence T. et al., A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes., [Epub ahead of print]., Neuro-Oncology, Dec 04, 2013

    Bandopadhayay P. et al., BET-bromodomain inhibition of MYC-amplified Medulloblastoma., [Epub ahead of print]., Clin. Cancer Res., Dec 02, 2013

    Smallridge R.C. et al., RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma., [Epub ahead of print]., Journal of Clinical Endocrinology & Metabolism, Dec 02, 2013

    Fierro-Monti I et al., Dynamic impacts of the inhibition of the molecular chaperone Hsp90 on the T-cell proteome have implications for anti-cancer therapy., [Epub ahead of print]., PLoS ONE, Nov 27, 2013

    Norton N. et al., Gene expression, single nucleotide variant and fusion transcript discovery in archival material from breast tumors., [Epub ahead of print]., PLoS ONE, Nov 22, 2013

    Iida N. et al., Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment., [Epub ahead of print]., Science, Nov 22, 2013

    Pogue-Geile K.L. et al., Predicting degree of benefit from adjuvant Trastuzumab in NSABP trial B-31., [Epub ahead of print]., J Natl Cancer Inst., Nov 21, 2013

    Sun J.M. et al., Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinoma., [Epub ahead of print]., Lung Cancer, Nov 20, 2013

    Paulus A. et al., AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia., [Epub ahead of print]., British J. Haematol., Nov 17, 2013